how safe are glp 1 GLP-1s? what glp 1 does Is

Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes

Many underlying issues remain untouched, including: Hormonal imbalances Insulin resistance Chronic inflammation Poor gut health Stress-related cortisol elevation Nutrient deficiencies When the medication is stopped, the body often rebounds because the root causes were never resolved

Payer coverage for Wegovy and Saxenda is even more limited than in the US, as summarized in the table below

Conversely, supply diversion to cosmetic use, inequitable access, and insufficient monitoring for side effects (gastrointestinal symptoms, rare pancreatitis concerns) could undermine benefits

It is observational, so it can only show associations